Basis: Trailing twelve months (TTM), to the latest fiscal quarter end. Source: stored company filings and market data; unavailable inputs remain N/A.
Is the return on equity (ROE) high or low?
The return on equity (ROE) of 14.23% is 274% above its 5-year average of -8.20%, near the high end of its 5-year range (-37.07%–14.23%).
As of the fiscal period ended Tuesday, June 30, 2026. 304.76% above its 12-month average of -6.95%.
Trailing-twelve-month return on equity at each fiscal quarter end; no daily interpolation. Q2 FY2026 (2026-06-30): 14.23%.
RETURN ON EQUITY (ROE)
14.23%
RETURN ON EQUITY (ROE) AVG TTM
-6.95%
RETURN ON EQUITY (ROE) AVG 3Y
-4.60%
RETURN ON EQUITY (ROE) AVG 5Y
-8.20%
RETURN ON EQUITY (ROE) AVG 10Y
-7.65%
RETURN ON EQUITY (ROE) AVG 15Y
-0.40%
RETURN ON EQUITY (ROE) AVG 20Y
2.23%
CURRENT VS TTM AVG
+304.76%
CURRENT VS 3Y AVG
+409.40%
CURRENT VS 5Y AVG
+273.62%
CURRENT VS 10Y AVG
+285.97%
CURRENT VS 15Y AVG
+3672.04%
CURRENT VS 20Y AVG
+539.29%
SECTOR MEDIAN · HEALTHCARE
-40.20%
median of 606 covered companies
CURRENT VS SECTOR MEDIAN
+135.39%
vs the sector median at left
LivaNova PLC
Market Cap
$4.16B
Return on Equity (ROE)
14.23%
TTM Avg
-6.95%
3Y Avg
-4.60%
5Y Avg
-8.20%
Market Cap
$4.15B
Return on Equity (ROE)
-18.38%
TTM Avg
-15.28%
3Y Avg
-7.60%
5Y Avg
-0.19%
Market Cap
$3.99B
Return on Equity (ROE)
1.40%
TTM Avg
-2.98%
3Y Avg
-2.73%
5Y Avg
0.21%
Market Cap
$4.36B
Return on Equity (ROE)
-42.32%
TTM Avg
-13.82%
3Y Avg
-5.11%
5Y Avg
-5.11%
Market Cap
$4.38B
Return on Equity (ROE)
-44.02%
TTM Avg
-30.64%
3Y Avg
-28.05%
5Y Avg
-12.80%
Market Cap
$4.44B
Return on Equity (ROE)
N/A
TTM Avg
-107.43%
3Y Avg
-58.28%
5Y Avg
-52.10%
Market Cap
$4.45B
Return on Equity (ROE)
-44.68%
TTM Avg
-52.94%
3Y Avg
-55.51%
5Y Avg
-46.01%
Market Cap
$4.62B
Return on Equity (ROE)
6.24%
TTM Avg
-11.62%
3Y Avg
-98.18%
5Y Avg
-98.18%
Market Cap
$4.65B
Return on Equity (ROE)
16.63%
TTM Avg
15.37%
3Y Avg
15.09%
5Y Avg
11.91%
| NAME | MARKET CAP | RETURN ON EQUITY (ROE) | TTM | 3Y | 5Y |
|---|---|---|---|---|---|
| LivaNova PLC (LIVN) | $4.16B | 14.23% | -6.95% | -4.60% | -8.20% |
| AbCellera Biologics Inc. (ABCL)vs › | $4.15B | -18.38% | -15.28% | -7.60% | -0.19% |
| ICU Medical, Inc. (ICUI)vs › | $3.99B | 1.40% | -2.98% | -2.73% | 0.21% |
| Heartflow, Inc. Common Stock (HTFL)vs › | $4.36B | -42.32% | -13.82% | -5.11% | -5.11% |
| Edgewise Therapeutics, Inc. (EWTX)vs › | $4.38B | -44.02% | -30.64% | -28.05% | -12.80% |
| Indivior Pharmaceuticals Inc (INDV)vs › | $4.44B | N/A | -107.43% | -58.28% | -52.10% |
| Adaptive Biotechnologies Corporation (ADPT)vs › | $4.45B | -44.68% | -52.94% | -55.51% | -46.01% |
| BillionToOne, Inc. (BLLN)vs › | $4.62B | 6.24% | -11.62% | -98.18% | -98.18% |
| Option Care Health, Inc. (OPCH)vs › | $4.65B | 16.63% | 15.37% | 15.09% | 11.91% |
| LifeStance Health Group, Inc. (LFST)vs › | $4.70B | 3.43% | -1.67% | -7.64% | -9.04% |
ROE
14.2%
ROA
7.1%
ROE = Net Income / Total Shareholders' Equity
Return on equity measures how efficiently a company generates profit from shareholders' equity. Higher ROE indicates better capital efficiency.
Expanded definitions: Investopedia, Wikipedia, Corporate Finance Institute
| DATE | RETURN ON EQUITY (ROE) |
|---|---|
| 2026-06-30 | 14.23% |
| 2026-03-31 | 8.84% |
| 2025-12-31 | -20.21% |
| 2025-09-30 | -18.79% |
| 2025-06-30 | -18.82% |
| 2025-03-31 | -21.48% |
| 2024-12-31 | 4.79% |
| 2024-09-30 | 1.81% |
| 2024-06-30 | -1.34% |
| 2024-03-31 | -2.60% |
| 2023-12-31 | 1.37% |
| 2023-09-30 | 0.23% |
| 2023-06-30 | -7.83% |
| 2023-03-31 | -6.67% |
| 2022-12-31 | -7.14% |
| 2022-09-30 | -8.41% |
| 2022-06-30 | -2.54% |
| 2022-03-31 | -8.17% |
| 2021-12-31 | -10.76% |
| 2021-09-30 | -31.57% |
| 2021-06-30 | -37.07% |
| 2021-03-31 | -39.14% |
| 2020-12-31 | -31.45% |
| 2020-09-30 | -15.43% |
| 2020-06-30 | -12.12% |
| 2020-03-31 | -7.38% |
| 2019-12-31 | -11.21% |
| 2019-09-30 | -14.88% |
| 2019-06-30 | -17.65% |
| 2019-03-31 | -14.63% |
| 2018-12-31 | -12.60% |
| 2018-09-30 | -5.07% |
| 2018-06-30 | -3.11% |
| 2018-03-31 | -1.27% |
| 2017-12-31 | -1.38% |
| 2017-09-30 | 2.97% |
| 2017-06-30 | 1.49% |
| 2017-03-31 | -0.64% |
| 2016-12-31 | -3.68% |
| 2015-04-30 | 20.92% |
| 2015-01-31 | 24.26% |
| 2014-10-31 | 23.39% |
| 2014-07-31 | 22.60% |
| 2014-04-30 | 21.18% |
| 2014-01-31 | 19.98% |
| 2013-10-31 | 20.03% |
| 2013-07-31 | 20.01% |
| 2013-04-30 | 20.19% |
| 2013-01-31 | 20.27% |
| 2012-10-31 | 20.41% |
| 2012-07-31 | 19.74% |
| 2012-04-30 | 19.66% |
| 2012-01-31 | 18.96% |
| 2011-10-31 | 18.48% |
| 2011-07-31 | 27.32% |
| 2011-04-30 | 26.63% |
| 2011-01-31 | 29.37% |
| 2010-10-31 | 32.95% |
| 2010-07-31 | 64.27% |
| 2010-04-30 | 70.76% |
| 2010-01-31 | 74.32% |
| 2009-10-31 | 84.98% |
| 2009-07-31 | 93.25% |
| 2009-04-30 | 109.46% |
| 2009-01-31 | 147.57% |
| 2008-10-31 | 333.74% |
| 2005-10-31 | -279.98% |
| 2005-07-31 | -47.52% |
| 2005-04-30 | -16.16% |
| 2005-01-31 | -9.91% |
| 2004-10-31 | -6.55% |
| 2004-07-31 | 1.80% |
| 2004-04-30 | 9.80% |
| 2004-01-31 | 17.86% |
| 2003-10-31 | 23.31% |
| 2003-07-31 | 21.69% |
| 2003-04-30 | 10.69% |
